Five Prime Therapeutics Announces Timing of Its Fourth Quarter 2020 and Full Year Results Conference Call
02 März 2021 - 10:05PM
Business Wire
Five Prime Therapeutics, Inc. (NASDAQ: FPRX), will report its
fourth quarter and full year 2020 operational and financial results
on Wednesday, March 10, 2021 after the U.S. financial markets
close. Five Prime will also host a conference call and live audio
webcast that same day at 4:30 p.m. (ET) / 1:30 p.m. (PT) to provide
a general business update and discuss the company’s financial
results.
The live audio webcast may be accessed through the "Events &
Presentations" page in the "Investors" section of the company's
website at www.fiveprime.com. Alternatively, participants may dial
(877) 878-2269 (domestic) or (253) 237-1188 (international) and
refer to conference ID: 9872966.
The archived conference call will be available on Five Prime's
website beginning approximately two hours after the event and will
be archived and available for replay for at least 30 days after the
event.
About Five Prime Therapeutics
Five Prime is a clinical stage biotechnology company
relentlessly focused on rewriting cancer. By tackling the tough
scientific questions and untapped pathways, we aim to offer new
hope by developing novel, breakthrough therapies that have
potential to alter the course of disease in cancers with few
treatment options. This vision is what defines us and guides our
research, clinical development and partnerships. To build a better
tomorrow for people with cancer, we are teaming up with patients,
physicians, scientists, and industry partners to make a meaningful
difference in patients’ lives. Five Prime collaborates with leading
global pharmaceutical companies and has therapies in pre-clinical
and clinical development. For more information, please visit
www.fiveprime.com.
Source: Five Prime Therapeutics, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210302006083/en/
Media and Investor Contact Martin Forrest VP, Investor
Relations & Corporate Communications Five Prime Therapeutics,
Inc. 415-365-5625 martin.forrest@fiveprime.com
Five Prime Therapeutics (NASDAQ:FPRX)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Five Prime Therapeutics (NASDAQ:FPRX)
Historical Stock Chart
Von Nov 2023 bis Nov 2024
Echtzeit-Nachrichten über Five Prime Therapeutics Inc (NASDAQ): 0 Nachrichtenartikel
Weitere Five Prime Therapeutics, Inc. News-Artikel